08.07.2013 17:59:00

WebPathology, UBM Medica US Partner, Extending High-Quality Pathology Images to Broad Distribution

NORWALK, Conn., July 8, 2013 /PRNewswire/ -- WebPathology.com announced today a unique marketing and distribution partnership with UBM Medica US. WebPathology is an online resource containing high-quality pathology images of benign and malignant tumors and related entities.

One of the largest media companies in the United States serving the healthcare industry, UBM Medica US delivers integrated and strategic communication solutions to a comprehensive audience of medical professionals and healthcare consumers through online, print, live, and custom programs.

"We are excited about partnering with UBM Medica. This collaboration will give us access to a wider audience and the additional resources available through this partnership will help us take WebPathology to the next level," said Dharam Ramnani, MD, founder of WebPathology.

Through this marketing and distribution partnership, medical professionals in all fields will have access to WebPathology's:

"Our new partnership with WebPathology offers our audience of medical professionals more visuals and insights into the field of pathology. We are excited for this partnership and the continued success of our network," said Barron Hirsch, Senior Director of Strategic Partnerships at UBM Medica US.

For more information, visit: www.WebPathology.com  

About WebPathology
WebPathology was launched in 2003 by Dr. Dharam Ramnani. It initially focused on urologic pathology and was subsequently expanded to include other organ systems. The site offers a visual survey of surgical pathology with emphasis on high-quality images. Each image is accompanied by a comment on pertinent clinical and pathologic features. WebPathology has become a valuable educational resource for pathology residents and trainees as well as practicing clinicians and allied health professionals around the world.

About UBM Medica US
Addressing today's healthcare information needs, UBM Medica US, delivers strategic, integrated communications solutions and comprehensive reach -- online, in print, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica US provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, online communities, drug databases, digital events, and other valuable resources, UBM Medica US also delivers comprehensive communication solutions for the pharmaceutical and related industries. Websites include CancerNetwork.com, ConsultantLive.com, DiagnosticImaging.com, RheumatologyNetwork.com, OBGYN.net, PhysiciansPractice.com, PsychiatricTimes.com and SearchMedica.com. UBM Medica US is part of UBM Connect – which provides marketing services across a number of communities, the largest of which are healthcare, medical device design and advanced manufacturing. UBM Connect also includes UBM Studios, the global leader in interactive digital environments. UBM Connect is a UBM plc company. For more information, visit www.UBMMedicaUS.com

About UBM plc
UBM plc is a global events-led marketing services and communications company.  We help businesses do business, bringing the world's buyers and sellers together at events and online, as well as producing and distributing news and specialist content. Our 5,500 staff in more than 30 countries are organised into expert teams which serve commercial and professional communities, helping them to do business and their markets to work effectively and efficiently.

For more information, go to www.ubm.com; follow us on Twitter at @UBM_plc to get the latest UBM corporate news.

Media Contacts:

WebPathology

For UBM Medica US

Dharam M. Ramnani, MD

Amy Erdman

804.683.7259

203.523.7041    

dmr@webpathology.com 

amy.erdman@ubm.com

SOURCE UBM Medica US

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!